Rxo, INC Schedule 13G passive stakes

Finepoint Capital LP and Herbert Wagner have filed an amendment to their Schedule 13G, reporting shared beneficial ownership of 5,355,445 shares, representing 3.2% of RXO, Inc.'s common stock.

Orbis Investment Management Limited, Allan Gray Australia Pty Ltd, and Orbis Investment Management (U.S.), L.P. have collectively reported beneficial ownership of 22.1% of RXO, Inc.'s common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 8,570,903 shares, representing 5.21% of RXO Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.54% of RXO Inc.'s common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership of RXO Inc. common stock due to an internal corporate realignment.

Orbis Investment Management Limited, Allan Gray Australia Pty Ltd, and Orbis Investment Management (U.S.), L.P. collectively reported beneficial ownership of 21.1% of RXO, Inc.'s common stock.

Finepoint Capital LP and Herbert Wagner have reported a 5.7% beneficial ownership stake in RXO, Inc., totaling 9,388,789 shares.

Wellington Management Group LLP and its affiliates have reported a 2.87% beneficial ownership stake in RXO, Inc. common stock as of December 31, 2025.

Orbis Investment Management Limited and its affiliates have increased their beneficial ownership in RXO, Inc. to 19.9% of common stock.

Orbis Investment Management Limited and its affiliates have disclosed a combined 19.1% passive beneficial ownership stake in RXO, Inc. common stock.

Orbis Investment Management Limited and Allan Gray Australia Pty Ltd have jointly disclosed a combined beneficial ownership of 18.4% in RXO, Inc.'s common stock through a Schedule 13G Amendment.

Wellington Management Group LLP and its affiliates have disclosed a passive beneficial ownership of 5.67% of RXO, Inc.'s common stock, totaling 9,259,421 shares.

MFN Partners and its affiliates have filed an Amendment No. 4 to Schedule 13G, reporting a 19.2% beneficial ownership stake in RXO, Inc., totaling 32,154,993 shares as of December 31, 2024.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a 14.0% beneficial ownership stake in RXO Inc.'s common stock as of December 31, 2024.

The Vanguard Group has filed an amended Schedule 13G, reporting a beneficial ownership of 10.69% of RXO Inc's Common Stock as of December 31, 2024.